CV (CapsoVision) Accumulated Depreciation: $-0.69 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CV CapsoVision Inc CV
10 GF Score
Price $6.42
! 1 Warning Sign
View Full Analysis

What is CapsoVision Accumulated Depreciation?

CapsoVision CV -4.86% 10 Accumulated Depreciation is $-0.69 Mil as of Jun. 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

CapsoVision's quarterly accumulated depreciation increased from Dec. 2025 ($-0.58 Mil) to Mar. 2026 ($-0.63 Mil) and increased from Mar. 2026 ($-0.63 Mil) to Jun. 2026 ($-0.69 Mil).

CapsoVision's annual accumulated depreciation increased from Dec. 2023 ($-0.15 Mil) to Dec. 2024 ($-0.36 Mil) and increased from Dec. 2024 ($-0.36 Mil) to Dec. 2025 ($-0.58 Mil).

CapsoVision Accumulated Depreciation Related Terms

CapsoVision Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for CapsoVision's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CapsoVision Accumulated Depreciation Chart

CapsoVision Annual Data
Trend Dec23 Dec24 Dec25
Accumulated Depreciation
-0.15 -0.36 -0.58

CapsoVision Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.47 -0.52 -0.58 -0.63 -0.69
CV
10GF Score
CapsoVision Inc CV
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CapsoVision Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-0.69 Mil mean?
CapsoVision (CV) has a Accumulated Depreciation of $-0.69 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on CapsoVision and its competitors.
Is CapsoVision's Accumulated Depreciation too high?
CapsoVision's current Accumulated Depreciation is $-0.69 Mil. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's Accumulated Depreciation compare to LAB and ELMD?
CapsoVision's Accumulated Depreciation of $-0.69 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on CapsoVision and its competitors. CapsoVision's current Accumulated Depreciation is $-0.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current Accumulated Depreciation of $-0.69 Mil. The current Accumulated Depreciation is $-0.69 Mil. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For CapsoVision (CV), the current Accumulated Depreciation is $-0.69 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CapsoVision Business Description

Other Exchanges H6U:Germany
Address 18805 Cox Avenue, Suite 250, Saratoga, CA, USA, 95070
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score

Get the complete analysis for CV

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.42
Price